Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Proton pump inhibitors provide the best heartburn relief

July 27, 2001

First market introduction announced for Zelmac

July 26, 2001

XTL and Dong Wha enter hepatitis C alliance

July 19, 2001

Solvay advances cilansetron to phase III for IBS

July 19, 2001

Enzo Biochem cleared to begin trial of immune regulation medicine for Crohn's disease

July 16, 2001

SangStat enters into collaborations geared toward next-generation RDP-58 molecules

July 16, 2001

Agents for HBV and HIV described in patent literature by Korean lab

July 13, 2001

Cangene halts pilot phase II trial of anti-HCV hyperimmune product

July 13, 2001

Protective effect demonstrated for FR-167653 against aspirin-induced gastric damage

July 13, 2001

Primary endpoint achieved in phase III trial of Gilead's adefovir dipivoxil for HBV

July 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...